2000
DOI: 10.1093/jac/46.2.311
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin

Abstract: A novel biodegradable system of D-,L-dilactide delivering pefloxacin was implanted in 104 rabbits with experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus (MRSA), 26 serving as controls. Animals were killed on each third day and viable bacterial counts and levels of pefloxacin in bone tissue were determined. A 99. 9% decrease in viable count of bacteria was achieved by day 12 and complete bacterial eradication on day 33. Pefloxacin was released gradually, reaching its peak on day 1… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
26
1
2

Year Published

2002
2002
2013
2013

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(32 citation statements)
references
References 6 publications
2
26
1
2
Order By: Relevance
“…Several previous in vitro and in vivo studies (1,6,17,25,28,30,32,39) have delineated the use of polymers in different chemistries (polylactides, copolymers of lactide and glycolide, polyanhydrides, and polycaprolactone) as systems for the delivery of various antibiotics. The same composites have uniformly given positive results for the treatment of experimental osteomyelitis (2,8,16,19,29,34,38). Previous studies have mainly focused on antibiotic release from polymer composites during a course of only 1 to 3 months, which is less than the desired optimum for the therapy of treatment-resistant bone infections.…”
Section: Discussionmentioning
confidence: 99%
“…Several previous in vitro and in vivo studies (1,6,17,25,28,30,32,39) have delineated the use of polymers in different chemistries (polylactides, copolymers of lactide and glycolide, polyanhydrides, and polycaprolactone) as systems for the delivery of various antibiotics. The same composites have uniformly given positive results for the treatment of experimental osteomyelitis (2,8,16,19,29,34,38). Previous studies have mainly focused on antibiotic release from polymer composites during a course of only 1 to 3 months, which is less than the desired optimum for the therapy of treatment-resistant bone infections.…”
Section: Discussionmentioning
confidence: 99%
“…After overnight growth, an inoculum of 2 ϫ 10 8 CFU/ml was prepared and applied for bacterial challenge. The polymer was prepared as described previously (8) by direct polymerization of lactic acid, with tin(II) octoate used as the catalyst. Ciprofloxacin (Bayer, Leverkusen, Germany) was incorporated at a 1:10 ratio.…”
Section: Methodsmentioning
confidence: 99%
“…They consisted of polymethylmethacrylate beads that release gentamicin locally. The main problem, however, with antibiotic-impregnated bone cement was the need for surgical removal upon the completion of drug release (8). To alleviate this difficulty, biodegradable materials were developed as antibiotic carriers.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Carriers for local delivery of antimicrobials have been developed, attempting to provide locally high concentrations of antibiotics (5). Some newly developed biodegradable carriers have been shown to be very potent for the eradication of experimental osteomyelitis (6,7). The semihydrate form of calcium sulfate (CaSO 4 ), commonly known as plaster of Paris, may be applied as a biodegradable system for local drug delivery.…”
mentioning
confidence: 99%